LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $545 | -52.4% | 500 | 0.0% | 0.00% | – |
Q2 2023 | $1,145 | -5.8% | 500 | 0.0% | 0.00% | – |
Q1 2023 | $1,215 | +27.2% | 500 | 0.0% | 0.00% | – |
Q4 2022 | $955 | -4.5% | 500 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | -71.4% | 500 | -55.1% | 0.00% | – |
Q2 2019 | $7,000 | +16.7% | 1,113 | 0.0% | 0.00% | – |
Q1 2019 | $6,000 | -14.3% | 1,113 | 0.0% | 0.00% | – |
Q4 2018 | $7,000 | -46.2% | 1,113 | -5.6% | 0.00% | – |
Q3 2018 | $13,000 | -97.3% | 1,179 | -97.1% | 0.00% | -100.0% |
Q2 2018 | $484,000 | +32.6% | 40,337 | -5.4% | 0.00% | +50.0% |
Q1 2018 | $365,000 | -12.3% | 42,643 | +1.3% | 0.00% | -33.3% |
Q4 2017 | $416,000 | -20.2% | 42,100 | -0.7% | 0.00% | -25.0% |
Q3 2017 | $521,000 | -26.1% | 42,385 | -1.2% | 0.00% | -33.3% |
Q2 2017 | $705,000 | +19.1% | 42,885 | +3.9% | 0.01% | +20.0% |
Q1 2017 | $592,000 | +9.0% | 41,270 | +5.0% | 0.01% | -16.7% |
Q4 2016 | $543,000 | -11.4% | 39,288 | -8.0% | 0.01% | -33.3% |
Q2 2016 | $613,000 | +18.1% | 42,705 | -1.6% | 0.01% | +12.5% |
Q1 2016 | $519,000 | -4.9% | 43,419 | +5.8% | 0.01% | -27.3% |
Q4 2015 | $546,000 | +10.8% | 41,033 | -10.6% | 0.01% | -8.3% |
Q3 2015 | $493,000 | +183.3% | 45,897 | +112.5% | 0.01% | +140.0% |
Q2 2015 | $174,000 | – | 21,597 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |